Status:
UNKNOWN
Anosmia and / or Ageusia and Early Corticosteroid Use
Lead Sponsor:
ClinAmygate
Conditions:
Covid19
Anosmia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Time to recover of Anosmia and / or ageusia and early corticosteroid use
Detailed Description
In a study of dexamethasone kinetics in two groups of 15 patients with community-acquired pneumonia, one group was treated with dexamethasone 6 mg/day by mouth and the other with 4 mg/day intravenousl...
Eligibility Criteria
Inclusion
- Any case with COVID-19
- Age more than or equal to 18 years
- Mild to moderate severity
Exclusion
- Diabetes
- Any contra-indication for the interventional drug
- Mentally disabled cases
Key Trial Info
Start Date :
March 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04528329
Start Date
March 30 2021
End Date
December 30 2023
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asalam
Maadi, Cairo Governorate, Egypt, 11433